Milestone Pharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference

Rhea-AI Summary

Milestone Pharmaceuticals Inc. (Nasdaq: MIST) announced that CEO Joseph Oliveto will present at the Jefferies Virtual London Healthcare Conference on November 18, 2020, at 7:55 AM ET. The event will be held online, allowing broader access. A live webcast of the presentation can be viewed on Milestone's website, with a replay available for 30 days post-event. Milestone focuses on developing innovative cardiovascular treatments, particularly etripamil, currently in Phase 3 clinical trials.

MONTREAL and CHARLOTTE, N.C., Nov. 11, 2020 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Joseph Oliveto, President and Chief Executive Officer, will present at the Jefferies Virtual London Healthcare Conference on Wednesday, November 18, 2020 at 7:55 AM ET. The conference will be held in a virtual meeting format.

A live webcast of the presentation can be accessed in the News & Events section of Milestone's website at www.milestonepharma.com. An archived replay of the webcast will be available on the same website for approximately 30 days following the presentation.

About Milestone Pharmaceuticals

Milestone Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of etripamil, a Phase 3 clinical-stage program, for the treatment of cardiovascular indications. Milestone Pharmaceuticals operates in Canada and the United States. For more information, visit www.milestonepharma.com and follow the Company on Twitter at @MilestonePharma.

Contact

David Pitts
Argot Partners
212-600-1902
david@argotpartners.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/milestone-pharmaceuticals-to-present-at-the-jefferies-virtual-london-healthcare-conference-301170433.html

SOURCE Milestone Pharmaceuticals, Inc.

FAQ

When will Milestone Pharmaceuticals present at the Jefferies Virtual London Healthcare Conference?

Milestone Pharmaceuticals will present at the Jefferies Virtual London Healthcare Conference on November 18, 2020, at 7:55 AM ET.

How can I access the live webcast of Milestone Pharmaceuticals' presentation?

The live webcast of Milestone Pharmaceuticals' presentation can be accessed through the News & Events section on their website.

What is the focus of Milestone Pharmaceuticals?

Milestone Pharmaceuticals focuses on developing and commercializing innovative cardiovascular medicines, particularly etripamil.

Is there a replay available for Milestone Pharmaceuticals' presentation?

Yes, an archived replay of Milestone Pharmaceuticals' presentation will be available on their website for approximately 30 days after the event.

What is the stock symbol for Milestone Pharmaceuticals?

The stock symbol for Milestone Pharmaceuticals is MIST.